The broad goal of this study was to examine the efficacy and tolerability of vortioxetine
(flexible dose) for the treatment of major depressive disorder (MDD) in symptomatic women
around the menopausal transition. We hypothesized that an eight-week treatment with
vortioxetine would promote a significant improvement of depression symptoms and other
menopause-related physical symptoms.
The broad goal of this study was to examine the efficacy and tolerability of vortioxetine
(flexible dose) for the treatment of major depressive disorder (MDD) in symptomatic women
around the menopausal transition. We hypothesized that an eight-week treatment with
vortioxetine would promote a significant improvement of depression symptoms and other
menopause-related physical symptoms.
Assessment in Work Productivity and the Relationship With Cognitive Symptoms in Patients With MDD Taking Vortioxetine
Completed
Lundbeck Canada Inc.
Phase 4
2015-02-01
The purpose of the study is to describe the association/correlation between change in
patient-reported cognitive symptoms and work productivity in gainfully employed patients
receiving vortioxetine for a Major Depressive Episode (MDE).
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
